Private Wealth Management Group’s Vir Biotechnology VIR Stock Holding History

Private Wealth Management Group’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.38K	Hold	920	–	–	﹤0.01%	601
2026 Q1	$8.24K	Hold	920	–	–	﹤0.01%	590
2025 Q4	$5.55K	Hold	920	–	–	﹤0.01%	731
2025 Q3	$5.25K	Hold	920	–	–	﹤0.01%	775
2025 Q2	$4.64K	Buy	+920	New	+$4.93K	﹤0.01%	785
2024 Q4	–	Sell	-51	Closed	-$382	–	1580
2024 Q3	$382	Sell	51 -272	-84%	-$2.36K	﹤0.01%	1448
2024 Q2	$2.88K	Buy	323 +272	+533%	+$2.61K	﹤0.01%	926
2024 Q1	$517	Hold	51	–	–	﹤0.01%	1440
2023 Q4	$514	Buy	+51	New	+$466	﹤0.01%	1456

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Private Wealth Management Group's VIR Position: Q2 2026 in Review

Private Wealth Management Group held its Vir Biotechnology (VIR) position steady in Q2 2026 at 920 shares worth $9.38K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

Private Wealth Management Group first reported a position in VIR in Q4 2023 and has held it in 9 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Private Wealth Management Group held 920 shares of Vir Biotechnology worth $9.38K as of Q2 2026.
Private Wealth Management Group left its Vir Biotechnology share count unchanged in Q2 2026.
Vir Biotechnology made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #601 holding.
Private Wealth Management Group first reported a position in Vir Biotechnology in Q4 2023 and has held it in 9 quarters since.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.